PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy

Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P. Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K. Maharjan, Urvi M. Patel, Umasankar De, Madison E. Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R. Shaffer, Kevin R. Guertin, Haoyang Zhuang, Emily Moser, Keiran S.M. Smalley, Dongwen Lv, Daohong ZhouGuangrong Zheng, Weizhou Zhang

Producción científica: Articlerevisión exhaustiva

4 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy'. En conjunto forman una huella única.

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology